Lacosamide 72603-0263-02
- Manufacturer
- Northstar Rxllc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- July 15, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA216335
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
72603-0263-02Selected10 VIAL, GLASS in 1 CARTON (72603-263-02) / 20 mL in 1 VIAL, GLASS (72603-263-01)